Navigation Links
International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
Date:5/24/2013

LOS ANGELES, May 24, 2013 /PRNewswire/ -- An international roster of experts on malignant pleural mesothelioma (MPM) gathered on Saturday, May 18, in Santa Monica, Calif., to discuss their latest research findings on new lung-sparing therapies for MPM, a rare form of cancer that results from exposure to asbestos and commonly affects the pleura, the lining of the chest.

Hosted by UCLA and the Pacific Heart, Lung and Blood Institute, the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma focused on research aimed at preserving vital lung function in MPM patients. Mesothelioma experts now agree that extrapleural pneumonectomy, which involves removal of the lung and surrounding diseased tissues, does not have a place in treatment of patients with this asbestos-related problem. Presentations included the latest surgical techniques for removal of cancerous tumors and a variety of adjunctive techniques.

Symposium leader, Robert B. Cameron , MD, FACS, Director of the UCLA Mesothelioma Comprehensive Research Program and Chief of Thoracic Surgery at the West Los Angeles VA Medical Center, presented treatment strategies and results of multimodality treatment of patients with sarcomatoid-type MPM, the fastest spreading and most difficult to treat form of the disease. He also discussed current thermal research at UCLA and the effectiveness of cryoablation in killing MPM cancer cells.

The symposium's distinguished faculty included Joseph S. Friedberg , MD, of the University of Pennsylvania, who presented promising new photodynamic therapy results using light to directly kill cancer cells; Olga Olevsky , MD, of UCLA Medical Center, who discussed results of a variety of novel treatment strategies; Italian Radiologist Marco Trovo, MD, who presented the early results of
'/>"/>

SOURCE The Pacific Meso Center
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Chindex International, Inc. to Report First Quarter 2012 Financial Results
7. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
8. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
9. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
10. Bacterin International Signs Its Third National GPO Contract with Novation
11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)...  Volcano Corporation (Nasdaq: VOLC ), ... economic outcomes on a global basis by developing ... visualization, physiology diagnostics and therapies, today confirmed receipt ... from Engaged Capital, LLC.  The Company issued the ... welcomes the perspectives of its shareholders, and has ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... 29, 2014  Cancer Treatment Institute of ... new drug treatment: a carefully formulated, first-of-its-kind combination ... proven successful at treating multiple types of cancer. ... treatment are optimistic that it could significantly improve ... therapeutic avenues. "These two drugs are ...
Breaking Medicine Technology:Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... GPRO ) announced today that the Company ... investigational APTIMA(R) assay to detect human,papillomavirus (HPV), which ... multi-center study was an important goal,for Gen-Probe in ... and,chief operating officer. "Enrolling our first patient last ...
... Alone and in combination with, Ramipril Global Endpoint ... Annual Scientific Session of the American College of ... online in the New England Journal of Medicine, ... the landmark,ONTARGET(TM) trial have demonstrated that MICARDIS(R) (telmisartan), ...
Cached Medicine Technology:Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 2Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 3Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 4Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer 5Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 2Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 3Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 4Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 5Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 6Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population 7
(Date:9/30/2014)... September 30, 2014 For Dr. Jim Pertsch, ... in San Mateo, CA, the decision was simple. “I was ... when I heard Miele offered a solution for cleaning surgical ... for ways to help the staff, and the Miele system ... and I don’t worry as much about the staff coming ...
(Date:9/30/2014)... CE-Classes.com has announced the addition of ... for Healthcare Providers. This course on treating tobacco addiction ... - substance abuse counselors, social workers, professional counselors, psychologists, ... implementation of this new course” said Ron Black, president ... smoking has tremendous value to our society.” , Appropriate ...
(Date:9/29/2014)... September 30, 2014 Shoulder pain is one ... with persistent shoulder pain generates nearly ¾ of the total ... of all adults will experience shoulder pain, and of those ... also been reported that 1 in 4 people with either ... than a year. , “This is a real problem, not ...
(Date:9/29/2014)... 30, 2014 Foundations Recovery Network, an ... the start of its 40th national conference by hosting ... a featured keynote speaker at the Moments of Change ... in the fields of addiction and mental health treatment. ... Fla., September 29 – October 2, 2014, at The ...
(Date:9/29/2014)... Boston, MA A retrospective study led by ... found an overuse of colonoscopies for colorectal cancer ... commonly recommended shorter follow-up intervals than established guidelines ... subsequent colonoscopy overuse. , "Our study shows ... being performed too early, resulting in use of ...
Breaking Medicine News(10 mins):Health News:Introducing a Safe, Time-Saving Solution for Ambulatory Surgery Centers 2Health News:Introducing a Safe, Time-Saving Solution for Ambulatory Surgery Centers 3Health News:CE-Classes.com Introduces New Online Course for Healthcare Providers 2Health News:CE-Classes.com Introduces New Online Course for Healthcare Providers 3Health News:KORT Physical Therapist Shines a Light on Shoulder Pain and Latest Treatments 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 3Health News:Endoscopists recommend frequent colonoscopies, leading to its overuse 2
... , , WASHINGTON, July 9 The ... the work of the National Organization on Disability,s (N.O.D.) ... emergency managers and the disability community as the only ... and personnel experienced in emergency management and disability issues. ...
... 9 The ongoing recession and associated job cuts ... employee benefit plans, slowing health insurer growth and pressuring ... and Consulting. , , "Conning projects that health ... resulting in deteriorating margins through 2011," said Terence Martin, ...
... Hospital for Special Surgery have shown that a biodegradable scaffold ... knee cartilage. The study is unique in that it used ... to examine how the plug incorporated itself into the knee. ... meeting of the American Orthopedic Society for Sports Medicine, June ...
... ... the world,s leading manufacturer and distributor of automated blood pressure monitors and health testing ... ... 2009 -- Lifeclinic International has named Lon von Hurwitz Executive Vice President ...
... externally , THURSDAY, July 9 (HealthDay News) -- U.S. ... ear infections in children. , Antibiotics are typically used ... for children with recurrent ear infections. , "The emergence ... surgical procedure raise the need to develop different ways ...
... 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... devices worldwide, today announced that it will report its,financial ... after the U.S.,market closes on August 10, 2009. Mindray,s ... on August 11, 2009 U.S. Eastern Time (8:00 PM ...
Cached Medicine News:Health News:Walmart Foundation Commits $500,000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 2Health News:Walmart Foundation Commits $500,000 to Improving Emergency Preparedness for the 54 Million Americans with Disabilities 3Health News:Conning Research: Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 2Health News:Study identifies potential fix for damaged knees 2Health News:Study identifies potential fix for damaged knees 3Health News:Pioneer of Digital Place-Based Media Joins World's Leading Blood Pressure and Health Kiosk Manufacturer 2Health News:Vaccine May Someday Thwart Ear Infections 2Health News:Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009 2
Curved shaft with flat 4.5 mm hook. Flat serrated handle with polished finish. Overall length: 5.3 inches....
... device allows for quick and ... ophthalmic surgical procedures. The "Quick ... through which a suture may ... during the loading procedure. The ...
Titanium. Small "H" shaped push-pull tip. Shaft angled 45 degrees, 9 mm from tip. Round knurled handle with dull finish. Overall length: 4.8 inches. Most popular size or model....
Left angled 5 mm blunt hook. Overall length: 9.9 inches....
Medicine Products: